( January 21, 2025, 3:24 PM EST) -- AMARILLO, Texas — The U.S. Food and Drug Administration on Jan. 18 asked a federal court in Texas to dismiss an amended complaint filed by Missouri, Kansas and Idaho in a case originated by a group of antiabortion advocates challenging the FDA’s approval of the abortion drug mifepristone, a case that eventually reached the U.S. Supreme Court, which found that the group lacked standing and in which the original plaintiffs have now voluntarily dismissed all of their claims....